Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
株式のランク
#3673
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
株価
$3.62
時価総額
$4.58B
変化（1日）
-0.16%
変化（1年）
-53.12%
国
CN
取引 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
カテゴリー
Healthcare
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.（603392）の営業利益率
October 2026 時点の営業利益率 TTM: -22.69%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. の最新の財務報告と株価によると、現在の営業利益率（TTM）は -22.69% です。2023 年末時点では 25.43% でした。
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. の営業利益率の履歴（2013 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | -22.69% | -642.82% |
| 2024 | 4.18% | -83.56% |
| 2023 | 25.43% | -49.17% |
| 2022 | 50.03% | 23.56% |
| 2021 | 40.49% | 22.96% |
| 2020 | 32.93% | 78.58% |
| 2019 | 18.44% | -37.32% |
| 2018 | 29.42% | 56.32% |
| 2017 | 18.82% | 20.87% |
| 2016 | 15.57% | -13.02% |
| 2015 | 17.90% | -7.40% |
| 2014 | 19.33% | 0.26% |
| 2013 | 19.28% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 38.59% | -101.70% |
US
|
|
| -149.01% | -93.43% |
US
|
|
| 25.57% | -101.13% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -101.27% |
NL
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。